Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
305.98
-8.12 (-2.59%)
Sep 29, 2026, 11:42 AM EDT - Market open
Ligand Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $345 | Buy | Maintains | $345 | +12.75% | Sep 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $358 | Buy | Maintains | $358 | +17.00% | Sep 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 23, 2026 |
| Citi | Citi | Buy Maintains $390 → $397 | Buy | Maintains | $390 → $397 | +29.75% | Sep 23, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $388 | Buy | Maintains | $388 | +26.81% | Sep 23, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 23, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $345 | Buy | Reiterates | $345 | +12.75% | Aug 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $326 | Buy | Reiterates | $326 | +6.54% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.